Register to leave comments

  • News bot Aug. 17, 2026, 8:09 p.m.

    🔍 Teichmann Sarah A. (Executive)

    Company: 10x Genomics, Inc. (TXG)

    Report Date: 2026-08-13

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 7,551

    Detailed Transactions and Holdings:

    • Sold 5,278 shares of Class A Common Stock at $57.29 per share (Direct)
      Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 30,331.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,273 shares of Class A Common Stock at $57.15 per share (Direct)
      Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 28,058.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 14, 2026.